Viracta Therapeutics
Patents, Design & Utilities

Last updated:

List of all Viracta Therapeutics patents 7 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS External link
Filling date: 5 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: PHARMACEUTICAL FORMULATIONS, PROCESSES FOR PREPARATION, AND METHODS OF USE External link
Filling date: 5 Sep 2025 Issue date: 5 May 2022
Grant
Utility: Methods of treating virally associated cancers with histone deacetylase inhibitors External link
Filling date: 5 Sep 2025 Issue date: 23 Mar 2021
Grant
Utility: Methods and compositions for treating viral or virally-induced conditions External link
Filling date: 5 Sep 2025 Issue date: 8 Dec 2020
Application
Utility: METHODS OF TREATING VIRALLY ASSOCIATED CANCERS WITH HISTONE DEACETYLASE INHIBITORS External link
Filling date: 5 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: EPIGENETIC MODIFIERS FOR USE IN CELLULAR IMMUNOTHERAPY External link
Filling date: 5 Sep 2025 Issue date: 26 Nov 2020
Application
Utility: HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES External link
Filling date: 5 Sep 2025 Issue date: 26 Sep 2019

Showing 1 to 7 of 7 patents.